Back to top Open menu arrow
Purchase PDF Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Insights June 1, 2021

Complex Polypharmacy in Bipolar Disorder

Which bipolar disorder patients are more likely to receive more than 2 medications, and why? In this video, Dr Goldberg discusses the findings of his recent systematic review focusing on polypharmacy in bipolar disorder.

Read the full article

Also from JCP

GLP-1RA and Renal Outcomes in Bipolar Disorder With Chronic Kidney Disease Cannabis Use and Time to Psychiatric Rehospitalization: A Survival Analysis Psilocybin-Assisted Therapy for Bipolar II Depression

From the Editors

New Series The JCP Podcast Stalling XT at 100 mg may actually raise the risk of GI-related dropout, while moving to 125 mg can improve tolerability and retention. This practical conversation gets into the dosing, ondansetron timing, and side effect clues that can make or break real-world use in schizophrenia.

About the Authors

Buy PDF for $40

Please sign in or purchase this PDF for $40.

The Journal of Clinical Psychiatry September 2026 cover featuring key articles on depression therapy

Vol 87 • 2026 • Number 3

Read the Current Issue

Original Research

Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression

Original Research

US Mortality Involving Obesity and Psychiatric Disorders

Academic Highlights

Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report

Original Research

Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms

Original Research

Exposure-Based Video Therapy for OCD and PTSD

Original Research

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
View current Issue

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe